Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen loss following CAR‐T cell therapy: Mechanisms, implications, and potential solutions
Archana Mishra, Rituparna Maiti, Prafull Mohan, et al.
European Journal Of Haematology (2023) Vol. 112, Iss. 2, pp. 211-222
Open Access | Times Cited: 24

Showing 24 citing articles:

Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy
Shaida Ouladan, Elias Orouji
Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 3
Tandem CAR-T cell therapy: recent advances and current challenges
Sara Gómez-Melero, Fakhri Hassouneh, Isabel M. Vallejo-Bermúdez, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 2
Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Christos Triantos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2631-2631
Open Access | Times Cited: 13
Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies
Haolong Lin, Xiuxiu Yang, Shanwei Ye, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117252-117252
Open Access | Times Cited: 11
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects
Paula Ercilla-Rodríguez, Marta Sánchez‐Díez, Nicolás Alegría‐Aravena, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
RESET: A reversible TCR-coupled antigen receptor with superior targeting sensitivity and pharmacologically controlled anti-tumor activity
Jardin Leleux, Jillian Rosenberg, Olmo Sonzogni, et al.
Molecular Therapy (2025)
Open Access
Multi-Targeting CAR-T Cell Strategies to Overcome Immune Evasion in Lymphoid and Myeloid Malignancies
Jessica Peter, Fabio Toppeta, Alexandre Trubert, et al.
Oncology Research and Treatment (2025), pp. 1-15
Closed Access
Prospects for the use of CAR-T-cell therapy in breast cancer: A look into the future
Л. Е. Сорокина, A. L. Nezlina, А. М. Krasnyi, et al.
Регенерация органов и тканей. (2025) Vol. 2, Iss. 2, pp. 10-23
Closed Access
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity
Lola Boutin, Mingzhi Liu, Julie Déchanet‐Merville, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access
SynNotch CAR-T cell, when synthetic biology and immunology meet again
Mohsen Shirzadian, Sepideh Moori, Ramin Rabbani, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Synthetic peptide hydrogels as a model of the bone marrow niche demonstrate efficacy of a combined CRISPR-CAR T-cell therapy for acute myeloid leukaemia
W. Sebastian Doherty-Boyd, Penelope M. Tsimbouri, Vineetha Jayawarna, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy
Sara Sadat Aghamiri, Rada Amin
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 5, pp. 321-321
Open Access
Robust differentiation of NK cells from MSLN.CAR-IL-15–engineered human iPSCs with enhanced antitumor efficacy against solid tumors
Qun Jiang, Weiming Yu, James Ma, et al.
Science Advances (2025) Vol. 11, Iss. 18
Open Access
A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?
Alain E. Andrea, Andrada Chiron, Guillaume Sarrabayrouse, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C.A. Quixabeira, James H.A. Clubb, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: where do we stand today?
Xiang Zhou, K. Martin Kortuem, Leo Rasche, et al.
La Presse Médicale (2024), pp. 104265-104265
Open Access | Times Cited: 2
Rewiring oncogenic signaling to RNA vector replication for the treatment of metastatic cancer
Xinzhi Zou, Chao Zhao, Kevin T. Beier, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptor
Kayla Myers Chen, Daniel Grun, Brian Gautier, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Therapeutic advantage of combinatorial CAR T cell and chemo-therapies
Meghan B Ward, Amber B. Jones, Giedre Krenciute
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100011-100011
Open Access
Ephrin-A2 and Phosphoantigen-Mediated Selective Killing of Medulloblastoma by γδT Cells Preserves Neuronal and Stem Cell Integrity
Lola Boutin, Mingzhi Liu, Julie Déchanet Merville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Single CAR-Dual target: Intracranial Delivery of Anti-PD-L1 CAR T Cells Effectively Eradicates Glioma and Immunosuppressive Cells in the Tumor Microenvironment.
María José Ulloa-Navas, Yan Luo, Jesus Emiliano Sanchez-Garavito, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top